Literature DB >> 2250720

Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells.

H te Riele1, E R Maandag, A Clarke, M Hooper, A Berns.   

Abstract

Specific genes can be inactivated or mutated in the mouse germ line. The phenotypic consequences of the mutation can provide pivotal information on the function of the gene in development and maintenance of the mammalian organism. The procedure entails homologous recombination in embryonic stem cells, which, on fusion to recipient blastocysts, give rise to chimaeric mice that can transmit the mutant gene to their offspring. Inbreeding can then yield mice carrying the mutation in both alleles allowing the phenotypic analysis of recessive mutations. In addition to mice lacking a particular gene function, cell lines carrying null alleles of normally expressed genes can be instrumental in assessing the function of the gene. These cell lines can either be obtained from homozygous animals or, should the mutation be lethal early in embryonic development, be generated by consecutive inactivation of both alleles by homologous recombination in cultured cells. Here we illustrate the feasibility of this latter approach by the efficient consecutive inactivation of both alleles of the pim-1 proto-oncogene in embryonic stem cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2250720     DOI: 10.1038/348649a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  70 in total

1.  Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP.

Authors:  U Konietzko; G Kauselmann; J Scafidi; U Staubli; H Mikkers; A Berns; M Schweizer; R Waltereit; D Kuhl
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Coupled homologous and nonhomologous repair of a double-strand break preserves genomic integrity in mammalian cells.

Authors:  C Richardson; M Jasin
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  A transgenic mouse strain expressing four drug-selectable marker genes.

Authors:  K L Tucker; Y Wang; J Dausman; R Jaenisch
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

4.  The molecular basis of multiple vector insertion by gene targeting in mammalian cells.

Authors:  P Ng; M D Baker
Journal:  Genetics       Date:  1999-03       Impact factor: 4.562

5.  Production of homozygous mutant ES cells with a single targeting construct.

Authors:  R M Mortensen; D A Conner; S Chao; A A Geisterfer-Lowrance; J G Seidman
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

6.  Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes.

Authors:  Roland H Friedel; Andrew Plump; Xiaowei Lu; Kerri Spilker; Christine Jolicoeur; Karen Wong; Tadmiri R Venkatesh; Avraham Yaron; Mary Hynes; Bin Chen; Ami Okada; Susan K McConnell; Helen Rayburn; Marc Tessier-Lavigne
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-29       Impact factor: 11.205

7.  Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs.

Authors:  H te Riele; E R Maandag; A Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

8.  Bi-allelic gene targeting in mouse embryonic stem cells.

Authors:  Peri H Tate; William C Skarnes
Journal:  Methods       Date:  2011-02-01       Impact factor: 3.608

9.  SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells.

Authors:  C Sumi-Ichinose; H Ichinose; D Metzger; P Chambon
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

10.  Selection against the dihydrofolate reductase-thymidylate synthase (DHFR-TS) locus as a probe of genetic alterations in Leishmania major.

Authors:  F J Gueiros-Filho; S M Beverley
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.